The SH2 containing adapter protein GRB10 interacts with BCR-ABL in yeast, in vitro and in vivo

被引：0
|
作者：
Duyster, J
Weidner, KM
Bai, RY
Gruss, HJ
Herrmann, F
机构：
[1] MAX DELBRUCK CTR MOL MED,BERLIN,GERMANY
[2] UNIV ULM,DEPT INTERNAL MED 3,D-7900 ULM,GERMANY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2685 / 2685
页数：1
相关论文
共 50 条
  • [41] THE SH2 SH3 DOMAIN-CONTAINING PROTEIN GRB2 INTERACTS WITH TYROSINE-PHOSPHORYLATED IRS1 AND SHC - IMPLICATIONS FOR INSULIN CONTROL OF RAS SIGNALING
    SKOLNIK, EY
    LEE, CH
    BATZER, A
    VICENTINI, LM
    ZHOU, M
    DALY, R
    MYERS, MJ
    BACKER, JM
    ULLRICH, A
    WHITE, MF
    SCHLESSINGER, J
    EMBO JOURNAL, 1993, 12 (05): : 1929 - 1936
  • [42] A coiled-coil tetramerization domain of BCR-ABL is essential for the interactions of SH2-containing signal transduction molecules
    Tauchi, T
    Miyazawa, K
    Feng, GS
    Broxmeyer, HE
    Toyama, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1389 - 1394
  • [43] SH2-containing phosphotyrosine phosphatase SHP-1 is involved in BCR-ABL signal transduction pathways.
    Tauchi, T
    Oneyama, C
    Yamashita, Y
    Sugimoto, S
    Toyama, K
    BLOOD, 1996, 88 (10) : 801 - 801
  • [44] Tyrosine phosphorylation of the GRB2 adapter protein by Bcr/Abl and EGF receptor: A novel regulatory mechanism for tyrosine kinase signaling.
    Li, SG
    Couvillon, A
    Brasher, BB
    Cantley, LC
    Van Etten, RA
    BLOOD, 2000, 96 (11) : 739A - 739A
  • [45] Autoantibodies binding to SH2 domain-containing adapter protein B as potential negative predictor for response of rituximab
    Ahmed, D.
    Witte, T.
    Lansche, C.
    Doerner, T.
    Schmidt, R.
    Baerlecken, N.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 24 - 25
  • [46] HSH2: A novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells
    Oda, T
    Muramatsu, M
    Isogai, T
    Masuho, Y
    Asano, S
    Yamashita, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (05) : 1078 - 1086
  • [47] Activity of the potent dual Abl/Src tyrosine kinase inhibitor FB2 against Bcr-Abl positive cell lines in vitro and in vivo
    Yuan, Xia
    Zhang, Yi
    Zhang, Haijing
    Jin, Jing
    Li, Xiangyan
    Liu, He
    Feng, Zhiqiang
    Chen, Xiaoguang
    LEUKEMIA RESEARCH, 2011, 35 (02) : 237 - 242
  • [48] Study of mutations in the ATP binding domain and the SH2/SH3 domain of BCR-ABL in 43 chronic myeloid leukemia patients treated by imatinib mesylate (STI571).
    Leguay, T
    Desplat, V
    Barthe, C
    Rousselot, P
    Reiffers, J
    Marit, G
    Mahon, FX
    BLOOD, 2002, 100 (11) : 369A - 369A
  • [49] PHOSPHORYLATION OF RECEPTOR PROTEIN-TYROSINE-PHOSPHATASE-ALPHA ON TYR789, A BINDING-SITE FOR THE SH3-SH2-SH3 ADAPTER PROTEIN GRB-2 IN-VIVO
    DENHERTOG, J
    TRACY, S
    HUNTER, T
    EMBO JOURNAL, 1994, 13 (13): : 3020 - 3032
  • [50] Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase
    Oda, T
    Kujovich, J
    Reis, M
    Newman, B
    Druker, BJ
    ONCOGENE, 1997, 15 (11) : 1255 - 1262
12345